Pharma & Healthcare
Global Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 11, 25
- ID: 298147
- Pages: 147
- Figures: 151
- Views: 38
In 2024, the global market size of Heparin was estimated to be worth US$ 2134 million and is forecast to reach approximately US$ 3489 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.
In this report, we mainly study the Heparin API.
Global key players of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, etc. The top five manufacturers hold a share about 54%. China is dominating the global Heparin market, has a share over 65% in terms of production. Europe and Asia-Pacific are the two largest market, both having a share about 34%, followed by North America, with a share about 30 percent.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Heparin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin.
The Heparin market size, estimations, and forecasts are provided in terms of sales volume (B Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Heparin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heparin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Pfizer
Bioibérica
Changzhou Qianhong Biopharma
Nanjing King-friend Biochemical Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Qingdao Jiulong Biopharmaceutical
Opocrin
Dongying Tiandong Pharmaceutical
Aspen Oss
Yino Pharma
Nanjing Xinbai Pharmaceutical
Hubei Enoray Biopharmaceutical
Cisen Pharmaceutical
Segment by Type
Heparin Sodium
Heparin Calcium
Segment by Application
UFH
LMWH
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Heparin in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Heparin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Heparin sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.
In this report, we mainly study the Heparin API.
Global key players of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, etc. The top five manufacturers hold a share about 54%. China is dominating the global Heparin market, has a share over 65% in terms of production. Europe and Asia-Pacific are the two largest market, both having a share about 34%, followed by North America, with a share about 30 percent.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Heparin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin.
The Heparin market size, estimations, and forecasts are provided in terms of sales volume (B Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Heparin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heparin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Pfizer
Bioibérica
Changzhou Qianhong Biopharma
Nanjing King-friend Biochemical Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Qingdao Jiulong Biopharmaceutical
Opocrin
Dongying Tiandong Pharmaceutical
Aspen Oss
Yino Pharma
Nanjing Xinbai Pharmaceutical
Hubei Enoray Biopharmaceutical
Cisen Pharmaceutical
Segment by Type
Heparin Sodium
Heparin Calcium
Segment by Application
UFH
LMWH
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Heparin in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Heparin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Heparin sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Heparin Product Introduction
1.2 Market by Type
1.2.1 Global Heparin Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Heparin Sodium
1.2.3 Heparin Calcium
1.3 Market by Application
1.3.1 Global Heparin Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 UFH
1.3.3 LMWH
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Heparin Market Size Estimates and Forecasts
2.1.1 Global Heparin Revenue 2020-2031
2.1.2 Global Heparin Sales 2020-2031
2.2 Heparin Market Size by Region: 2024 Versus 2031
2.3 Heparin Sales by Region (2020-2031)
2.3.1 Global Heparin Sales by Region: 2020-2025
2.3.2 Global Heparin Sales Forecast by Region (2026-2031)
2.3.3 Global Heparin Sales Market Share by Region (2020-2031)
2.4 Heparin Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Heparin Revenue by Region: 2020-2025
2.4.2 Global Heparin Revenue Forecast by Region (2026-2031)
2.4.3 Global Heparin Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Heparin Sales by Type (2020-2031)
3.1.1.1 Global Heparin Sales Volume by Type (2020-2031)
3.1.1.2 Global Heparin Sales Market Share by Type (2020-2031)
3.1.2 Global Heparin Revenue by Type (2020-2031)
3.1.2.1 Global Heparin Revenue by Type (2020-2031)
3.1.2.2 Global Heparin Revenue Market Share by Type (2020-2031)
3.1.3 Heparin Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Heparin Sales by Application (2020-2031)
3.2.1.1 Global Heparin Sales Volume by Application (2020-2031)
3.2.1.2 Global Heparin Sales Market Share by Application (2020-2031)
3.2.2 Global Heparin Revenue by Application (2020-2031)
3.2.2.1 Global Heparin Revenue by Application (2020-2031)
3.2.2.2 Global Heparin Revenue Market Share by Application (2020-2031)
3.2.3 Heparin Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Heparin Sodium of Heparin Revenue Market Share by Application
3.3.2 Heparin Calcium of Heparin Revenue Market Share by Application
4 Global Heparin by Manufacturers
4.1 Global Top Heparin Manufacturers by Sales (2020-2025)
4.1.1 Global Heparin Sales by Manufacturer (2020-2025)
4.1.2 Global Heparin Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Heparin Manufacturers by Revenue (2020-2025)
4.2.1 Global Heparin Revenue by Manufacturer (2020-2025)
4.2.2 Global Heparin Revenue Share by Manufacturer (2020-2025)
4.3 Global Heparin Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Heparin Manufacturers Covered: Ranking by Revenue
4.4.2 Global Heparin Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Heparin Manufacturing Base Distribution, Product Type
4.5.1 Heparin Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Heparin Market
4.5.3 Manufacturers Heparin Product Type and Application
4.5.4 Heparin Sodium Market Sales of Heparin by Manufacturer
4.5.5 Heparin Calcium Market Sales of Heparin by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Shenzhen Hepalink Pharmaceutical
5.1.1 Shenzhen Hepalink Pharmaceutical Company Information
5.1.2 Shenzhen Hepalink Pharmaceutical Description, Business Overview
5.1.3 Shenzhen Hepalink Pharmaceutical Heparin Products Offered
5.1.4 Shenzhen Hepalink Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Shenzhen Hepalink Pharmaceutical Heparin Sales by Product in 2024
5.1.6 Shenzhen Hepalink Pharmaceutical Heparin Sales by Application in 2024
5.1.7 Shenzhen Hepalink Pharmaceutical Heparin Sales by Geographic Area in 2024
5.1.8 Shenzhen Hepalink Pharmaceutical Recent Developments
5.2 Yantai Dongcheng Pharmaceutical
5.2.1 Yantai Dongcheng Pharmaceutical Company Information
5.2.2 Yantai Dongcheng Pharmaceutical Description, Business Overview
5.2.3 Yantai Dongcheng Pharmaceutical Heparin Products Offered
5.2.4 Yantai Dongcheng Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Yantai Dongcheng Pharmaceutical Heparin Sales by Product in 2024
5.2.6 Yantai Dongcheng Pharmaceutical Heparin Sales by Application in 2024
5.2.7 Yantai Dongcheng Pharmaceutical Heparin Sales by Geographic Area in 2024
5.2.8 Yantai Dongcheng Pharmaceutical Recent Developments
5.3 Pfizer
5.3.1 Pfizer Company Information
5.3.2 Pfizer Description, Business Overview
5.3.3 Pfizer Heparin Products Offered
5.3.4 Pfizer Heparin Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Pfizer Heparin Sales by Product in 2024
5.3.6 Pfizer Heparin Sales by Application in 2024
5.3.7 Pfizer Heparin Sales by Geographic Area in 2024
5.3.8 Pfizer Recent Developments
5.4 Bioibérica
5.4.1 Bioibérica Company Information
5.4.2 Bioibérica Description, Business Overview
5.4.3 Bioibérica Heparin Products Offered
5.4.4 Bioibérica Heparin Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Bioibérica Heparin Sales by Product in 2024
5.4.6 Bioibérica Heparin Sales by Application in 2024
5.4.7 Bioibérica Heparin Sales by Geographic Area in 2024
5.4.8 Bioibérica Recent Developments
5.5 Changzhou Qianhong Biopharma
5.5.1 Changzhou Qianhong Biopharma Company Information
5.5.2 Changzhou Qianhong Biopharma Description, Business Overview
5.5.3 Changzhou Qianhong Biopharma Heparin Products Offered
5.5.4 Changzhou Qianhong Biopharma Heparin Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Changzhou Qianhong Biopharma Heparin Sales by Product in 2024
5.5.6 Changzhou Qianhong Biopharma Heparin Sales by Application in 2024
5.5.7 Changzhou Qianhong Biopharma Heparin Sales by Geographic Area in 2024
5.5.8 Changzhou Qianhong Biopharma Recent Developments
5.6 Nanjing King-friend Biochemical Pharmaceutical
5.6.1 Nanjing King-friend Biochemical Pharmaceutical Company Information
5.6.2 Nanjing King-friend Biochemical Pharmaceutical Description, Business Overview
5.6.3 Nanjing King-friend Biochemical Pharmaceutical Heparin Products Offered
5.6.4 Nanjing King-friend Biochemical Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Nanjing King-friend Biochemical Pharmaceutical Heparin Sales by Product in 2024
5.6.6 Nanjing King-friend Biochemical Pharmaceutical Heparin Sales by Application in 2024
5.6.7 Nanjing King-friend Biochemical Pharmaceutical Heparin Sales by Geographic Area in 2024
5.6.8 Nanjing King-friend Biochemical Pharmaceutical Recent Developments
5.7 Hebei Changshan Biochemical Pharmaceutical
5.7.1 Hebei Changshan Biochemical Pharmaceutical Company Information
5.7.2 Hebei Changshan Biochemical Pharmaceutical Description, Business Overview
5.7.3 Hebei Changshan Biochemical Pharmaceutical Heparin Products Offered
5.7.4 Hebei Changshan Biochemical Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Hebei Changshan Biochemical Pharmaceutical Heparin Sales by Product in 2024
5.7.6 Hebei Changshan Biochemical Pharmaceutical Heparin Sales by Application in 2024
5.7.7 Hebei Changshan Biochemical Pharmaceutical Heparin Sales by Geographic Area in 2024
5.7.8 Hebei Changshan Biochemical Pharmaceutical Recent Developments
5.8 Qingdao Jiulong Biopharmaceutical
5.8.1 Qingdao Jiulong Biopharmaceutical Company Information
5.8.2 Qingdao Jiulong Biopharmaceutical Description, Business Overview
5.8.3 Qingdao Jiulong Biopharmaceutical Heparin Products Offered
5.8.4 Qingdao Jiulong Biopharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Qingdao Jiulong Biopharmaceutical Heparin Sales by Product in 2024
5.8.6 Qingdao Jiulong Biopharmaceutical Heparin Sales by Application in 2024
5.8.7 Qingdao Jiulong Biopharmaceutical Heparin Sales by Geographic Area in 2024
5.8.8 Qingdao Jiulong Biopharmaceutical Recent Developments
5.9 Opocrin
5.9.1 Opocrin Company Information
5.9.2 Opocrin Description, Business Overview
5.9.3 Opocrin Heparin Products Offered
5.9.4 Opocrin Heparin Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Opocrin Heparin Sales by Product in 2024
5.9.6 Opocrin Heparin Sales by Application in 2024
5.9.7 Opocrin Heparin Sales by Geographic Area in 2024
5.9.8 Opocrin Recent Developments
5.10 Dongying Tiandong Pharmaceutical
5.10.1 Dongying Tiandong Pharmaceutical Company Information
5.10.2 Dongying Tiandong Pharmaceutical Description, Business Overview
5.10.3 Dongying Tiandong Pharmaceutical Heparin Products Offered
5.10.4 Dongying Tiandong Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Dongying Tiandong Pharmaceutical Heparin Sales by Product in 2024
5.10.6 Dongying Tiandong Pharmaceutical Heparin Sales by Application in 2024
5.10.7 Dongying Tiandong Pharmaceutical Heparin Sales by Geographic Area in 2024
5.10.8 Dongying Tiandong Pharmaceutical Recent Developments
5.11 Aspen Oss
5.11.1 Aspen Oss Company Information
5.11.2 Aspen Oss Description, Business Overview
5.11.3 Aspen Oss Heparin Products Offered
5.11.4 Aspen Oss Heparin Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Aspen Oss Heparin Sales by Product in 2024
5.11.6 Aspen Oss Heparin Sales by Application in 2024
5.11.7 Aspen Oss Heparin Sales by Geographic Area in 2024
5.11.8 Aspen Oss Recent Developments
5.12 Yino Pharma
5.12.1 Yino Pharma Company Information
5.12.2 Yino Pharma Description, Business Overview
5.12.3 Yino Pharma Heparin Products Offered
5.12.4 Yino Pharma Heparin Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Yino Pharma Heparin Sales by Product in 2024
5.12.6 Yino Pharma Heparin Sales by Application in 2024
5.12.7 Yino Pharma Heparin Sales by Geographic Area in 2024
5.12.8 Yino Pharma Recent Developments
5.13 Nanjing Xinbai Pharmaceutical
5.13.1 Nanjing Xinbai Pharmaceutical Company Information
5.13.2 Nanjing Xinbai Pharmaceutical Description, Business Overview
5.13.3 Nanjing Xinbai Pharmaceutical Heparin Products Offered
5.13.4 Nanjing Xinbai Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Nanjing Xinbai Pharmaceutical Heparin Sales by Product in 2024
5.13.6 Nanjing Xinbai Pharmaceutical Heparin Sales by Application in 2024
5.13.7 Nanjing Xinbai Pharmaceutical Heparin Sales by Geographic Area in 2024
5.13.8 Nanjing Xinbai Pharmaceutical Recent Developments
5.14 Hubei Enoray Biopharmaceutical
5.14.1 Hubei Enoray Biopharmaceutical Company Information
5.14.2 Hubei Enoray Biopharmaceutical Description, Business Overview
5.14.3 Hubei Enoray Biopharmaceutical Heparin Products Offered
5.14.4 Hubei Enoray Biopharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
5.14.5 Hubei Enoray Biopharmaceutical Heparin Sales by Product in 2024
5.14.6 Hubei Enoray Biopharmaceutical Heparin Sales by Application in 2024
5.14.7 Hubei Enoray Biopharmaceutical Heparin Sales by Geographic Area in 2024
5.14.8 Hubei Enoray Biopharmaceutical Recent Developments
5.15 Cisen Pharmaceutical
5.15.1 Cisen Pharmaceutical Company Information
5.15.2 Cisen Pharmaceutical Description, Business Overview
5.15.3 Cisen Pharmaceutical Heparin Products Offered
5.15.4 Cisen Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
5.15.5 Cisen Pharmaceutical Heparin Sales by Product in 2024
5.15.6 Cisen Pharmaceutical Heparin Sales by Application in 2024
5.15.7 Cisen Pharmaceutical Heparin Sales by Geographic Area in 2024
5.15.8 Cisen Pharmaceutical Recent Developments
6 North America
6.1 North America Heparin Market Size YoY Growth 2020-2031
6.2 North America Heparin Market Facts & Figures by Country
6.2.1 North America Heparin Sales by Country (2020-2031)
6.2.2 North America Heparin Revenue by Country (2020-2031)
6.3 North America Heparin Sales by Type (2020-2025)
6.4 North America Heparin Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Heparin Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Heparin Market Facts & Figures by Region
7.2.1 Asia-Pacific Heparin Sales by Region (2020-2031)
7.2.2 Asia-Pacific Heparin Revenue by Region (2020-2031)
7.3 Asia-Pacific Heparin Sales by Type (2020-2025)
7.4 Asia-Pacific Heparin Sales by Application (2020-2025)
8 Europe
8.1 Europe Heparin Market Size YoY Growth 2020-2031
8.2 Europe Heparin Market Facts & Figures by Country
8.2.1 Europe Heparin Sales by Country (2020-2031)
8.2.2 Europe Heparin Revenue by Country (2020-2031)
8.3 Europe Heparin Sales by Type (2020-2025)
8.4 Europe Heparin Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Heparin Market Size YoY Growth 2020-2031
9.2 Latin America Heparin Market Facts & Figures by Country
9.2.1 Latin America Heparin Sales by Country (2020-2031)
9.2.2 Latin America Heparin Revenue by Country (2020-2031)
9.3 Latin America Heparin Sales by Type (2020-2025)
9.4 Latin America Heparin Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Heparin Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Heparin Market Facts & Figures by Country
10.2.1 Middle East and Africa Heparin Sales by Country (2020-2031)
10.2.2 Middle East and Africa Heparin Revenue by Country (2020-2031)
10.3 Middle East and Africa Heparin Sales by Type (2020-2025)
10.4 Middle East and Africa Heparin Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Heparin Supply Chain Analysis
11.2 Heparin Key Raw Materials and Upstream Suppliers
11.3 Heparin Clients Analysis
11.4 Heparin Sales Channel and Sales Model Analysis
11.4.1 Heparin Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Heparin Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Heparin Distributors
12 Heparin Market Dynamics
12.1 Heparin Industry Trends
12.2 Heparin Market Drivers
12.3 Heparin Market Challenges
12.4 Heparin Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Heparin Product Introduction
1.2 Market by Type
1.2.1 Global Heparin Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Heparin Sodium
1.2.3 Heparin Calcium
1.3 Market by Application
1.3.1 Global Heparin Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 UFH
1.3.3 LMWH
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Heparin Market Size Estimates and Forecasts
2.1.1 Global Heparin Revenue 2020-2031
2.1.2 Global Heparin Sales 2020-2031
2.2 Heparin Market Size by Region: 2024 Versus 2031
2.3 Heparin Sales by Region (2020-2031)
2.3.1 Global Heparin Sales by Region: 2020-2025
2.3.2 Global Heparin Sales Forecast by Region (2026-2031)
2.3.3 Global Heparin Sales Market Share by Region (2020-2031)
2.4 Heparin Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Heparin Revenue by Region: 2020-2025
2.4.2 Global Heparin Revenue Forecast by Region (2026-2031)
2.4.3 Global Heparin Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Heparin Sales by Type (2020-2031)
3.1.1.1 Global Heparin Sales Volume by Type (2020-2031)
3.1.1.2 Global Heparin Sales Market Share by Type (2020-2031)
3.1.2 Global Heparin Revenue by Type (2020-2031)
3.1.2.1 Global Heparin Revenue by Type (2020-2031)
3.1.2.2 Global Heparin Revenue Market Share by Type (2020-2031)
3.1.3 Heparin Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Heparin Sales by Application (2020-2031)
3.2.1.1 Global Heparin Sales Volume by Application (2020-2031)
3.2.1.2 Global Heparin Sales Market Share by Application (2020-2031)
3.2.2 Global Heparin Revenue by Application (2020-2031)
3.2.2.1 Global Heparin Revenue by Application (2020-2031)
3.2.2.2 Global Heparin Revenue Market Share by Application (2020-2031)
3.2.3 Heparin Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Heparin Sodium of Heparin Revenue Market Share by Application
3.3.2 Heparin Calcium of Heparin Revenue Market Share by Application
4 Global Heparin by Manufacturers
4.1 Global Top Heparin Manufacturers by Sales (2020-2025)
4.1.1 Global Heparin Sales by Manufacturer (2020-2025)
4.1.2 Global Heparin Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Heparin Manufacturers by Revenue (2020-2025)
4.2.1 Global Heparin Revenue by Manufacturer (2020-2025)
4.2.2 Global Heparin Revenue Share by Manufacturer (2020-2025)
4.3 Global Heparin Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Heparin Manufacturers Covered: Ranking by Revenue
4.4.2 Global Heparin Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Heparin Manufacturing Base Distribution, Product Type
4.5.1 Heparin Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Heparin Market
4.5.3 Manufacturers Heparin Product Type and Application
4.5.4 Heparin Sodium Market Sales of Heparin by Manufacturer
4.5.5 Heparin Calcium Market Sales of Heparin by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Shenzhen Hepalink Pharmaceutical
5.1.1 Shenzhen Hepalink Pharmaceutical Company Information
5.1.2 Shenzhen Hepalink Pharmaceutical Description, Business Overview
5.1.3 Shenzhen Hepalink Pharmaceutical Heparin Products Offered
5.1.4 Shenzhen Hepalink Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Shenzhen Hepalink Pharmaceutical Heparin Sales by Product in 2024
5.1.6 Shenzhen Hepalink Pharmaceutical Heparin Sales by Application in 2024
5.1.7 Shenzhen Hepalink Pharmaceutical Heparin Sales by Geographic Area in 2024
5.1.8 Shenzhen Hepalink Pharmaceutical Recent Developments
5.2 Yantai Dongcheng Pharmaceutical
5.2.1 Yantai Dongcheng Pharmaceutical Company Information
5.2.2 Yantai Dongcheng Pharmaceutical Description, Business Overview
5.2.3 Yantai Dongcheng Pharmaceutical Heparin Products Offered
5.2.4 Yantai Dongcheng Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Yantai Dongcheng Pharmaceutical Heparin Sales by Product in 2024
5.2.6 Yantai Dongcheng Pharmaceutical Heparin Sales by Application in 2024
5.2.7 Yantai Dongcheng Pharmaceutical Heparin Sales by Geographic Area in 2024
5.2.8 Yantai Dongcheng Pharmaceutical Recent Developments
5.3 Pfizer
5.3.1 Pfizer Company Information
5.3.2 Pfizer Description, Business Overview
5.3.3 Pfizer Heparin Products Offered
5.3.4 Pfizer Heparin Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Pfizer Heparin Sales by Product in 2024
5.3.6 Pfizer Heparin Sales by Application in 2024
5.3.7 Pfizer Heparin Sales by Geographic Area in 2024
5.3.8 Pfizer Recent Developments
5.4 Bioibérica
5.4.1 Bioibérica Company Information
5.4.2 Bioibérica Description, Business Overview
5.4.3 Bioibérica Heparin Products Offered
5.4.4 Bioibérica Heparin Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Bioibérica Heparin Sales by Product in 2024
5.4.6 Bioibérica Heparin Sales by Application in 2024
5.4.7 Bioibérica Heparin Sales by Geographic Area in 2024
5.4.8 Bioibérica Recent Developments
5.5 Changzhou Qianhong Biopharma
5.5.1 Changzhou Qianhong Biopharma Company Information
5.5.2 Changzhou Qianhong Biopharma Description, Business Overview
5.5.3 Changzhou Qianhong Biopharma Heparin Products Offered
5.5.4 Changzhou Qianhong Biopharma Heparin Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Changzhou Qianhong Biopharma Heparin Sales by Product in 2024
5.5.6 Changzhou Qianhong Biopharma Heparin Sales by Application in 2024
5.5.7 Changzhou Qianhong Biopharma Heparin Sales by Geographic Area in 2024
5.5.8 Changzhou Qianhong Biopharma Recent Developments
5.6 Nanjing King-friend Biochemical Pharmaceutical
5.6.1 Nanjing King-friend Biochemical Pharmaceutical Company Information
5.6.2 Nanjing King-friend Biochemical Pharmaceutical Description, Business Overview
5.6.3 Nanjing King-friend Biochemical Pharmaceutical Heparin Products Offered
5.6.4 Nanjing King-friend Biochemical Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Nanjing King-friend Biochemical Pharmaceutical Heparin Sales by Product in 2024
5.6.6 Nanjing King-friend Biochemical Pharmaceutical Heparin Sales by Application in 2024
5.6.7 Nanjing King-friend Biochemical Pharmaceutical Heparin Sales by Geographic Area in 2024
5.6.8 Nanjing King-friend Biochemical Pharmaceutical Recent Developments
5.7 Hebei Changshan Biochemical Pharmaceutical
5.7.1 Hebei Changshan Biochemical Pharmaceutical Company Information
5.7.2 Hebei Changshan Biochemical Pharmaceutical Description, Business Overview
5.7.3 Hebei Changshan Biochemical Pharmaceutical Heparin Products Offered
5.7.4 Hebei Changshan Biochemical Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Hebei Changshan Biochemical Pharmaceutical Heparin Sales by Product in 2024
5.7.6 Hebei Changshan Biochemical Pharmaceutical Heparin Sales by Application in 2024
5.7.7 Hebei Changshan Biochemical Pharmaceutical Heparin Sales by Geographic Area in 2024
5.7.8 Hebei Changshan Biochemical Pharmaceutical Recent Developments
5.8 Qingdao Jiulong Biopharmaceutical
5.8.1 Qingdao Jiulong Biopharmaceutical Company Information
5.8.2 Qingdao Jiulong Biopharmaceutical Description, Business Overview
5.8.3 Qingdao Jiulong Biopharmaceutical Heparin Products Offered
5.8.4 Qingdao Jiulong Biopharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Qingdao Jiulong Biopharmaceutical Heparin Sales by Product in 2024
5.8.6 Qingdao Jiulong Biopharmaceutical Heparin Sales by Application in 2024
5.8.7 Qingdao Jiulong Biopharmaceutical Heparin Sales by Geographic Area in 2024
5.8.8 Qingdao Jiulong Biopharmaceutical Recent Developments
5.9 Opocrin
5.9.1 Opocrin Company Information
5.9.2 Opocrin Description, Business Overview
5.9.3 Opocrin Heparin Products Offered
5.9.4 Opocrin Heparin Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Opocrin Heparin Sales by Product in 2024
5.9.6 Opocrin Heparin Sales by Application in 2024
5.9.7 Opocrin Heparin Sales by Geographic Area in 2024
5.9.8 Opocrin Recent Developments
5.10 Dongying Tiandong Pharmaceutical
5.10.1 Dongying Tiandong Pharmaceutical Company Information
5.10.2 Dongying Tiandong Pharmaceutical Description, Business Overview
5.10.3 Dongying Tiandong Pharmaceutical Heparin Products Offered
5.10.4 Dongying Tiandong Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Dongying Tiandong Pharmaceutical Heparin Sales by Product in 2024
5.10.6 Dongying Tiandong Pharmaceutical Heparin Sales by Application in 2024
5.10.7 Dongying Tiandong Pharmaceutical Heparin Sales by Geographic Area in 2024
5.10.8 Dongying Tiandong Pharmaceutical Recent Developments
5.11 Aspen Oss
5.11.1 Aspen Oss Company Information
5.11.2 Aspen Oss Description, Business Overview
5.11.3 Aspen Oss Heparin Products Offered
5.11.4 Aspen Oss Heparin Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Aspen Oss Heparin Sales by Product in 2024
5.11.6 Aspen Oss Heparin Sales by Application in 2024
5.11.7 Aspen Oss Heparin Sales by Geographic Area in 2024
5.11.8 Aspen Oss Recent Developments
5.12 Yino Pharma
5.12.1 Yino Pharma Company Information
5.12.2 Yino Pharma Description, Business Overview
5.12.3 Yino Pharma Heparin Products Offered
5.12.4 Yino Pharma Heparin Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Yino Pharma Heparin Sales by Product in 2024
5.12.6 Yino Pharma Heparin Sales by Application in 2024
5.12.7 Yino Pharma Heparin Sales by Geographic Area in 2024
5.12.8 Yino Pharma Recent Developments
5.13 Nanjing Xinbai Pharmaceutical
5.13.1 Nanjing Xinbai Pharmaceutical Company Information
5.13.2 Nanjing Xinbai Pharmaceutical Description, Business Overview
5.13.3 Nanjing Xinbai Pharmaceutical Heparin Products Offered
5.13.4 Nanjing Xinbai Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Nanjing Xinbai Pharmaceutical Heparin Sales by Product in 2024
5.13.6 Nanjing Xinbai Pharmaceutical Heparin Sales by Application in 2024
5.13.7 Nanjing Xinbai Pharmaceutical Heparin Sales by Geographic Area in 2024
5.13.8 Nanjing Xinbai Pharmaceutical Recent Developments
5.14 Hubei Enoray Biopharmaceutical
5.14.1 Hubei Enoray Biopharmaceutical Company Information
5.14.2 Hubei Enoray Biopharmaceutical Description, Business Overview
5.14.3 Hubei Enoray Biopharmaceutical Heparin Products Offered
5.14.4 Hubei Enoray Biopharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
5.14.5 Hubei Enoray Biopharmaceutical Heparin Sales by Product in 2024
5.14.6 Hubei Enoray Biopharmaceutical Heparin Sales by Application in 2024
5.14.7 Hubei Enoray Biopharmaceutical Heparin Sales by Geographic Area in 2024
5.14.8 Hubei Enoray Biopharmaceutical Recent Developments
5.15 Cisen Pharmaceutical
5.15.1 Cisen Pharmaceutical Company Information
5.15.2 Cisen Pharmaceutical Description, Business Overview
5.15.3 Cisen Pharmaceutical Heparin Products Offered
5.15.4 Cisen Pharmaceutical Heparin Sales, Revenue and Gross Margin (2020-2025)
5.15.5 Cisen Pharmaceutical Heparin Sales by Product in 2024
5.15.6 Cisen Pharmaceutical Heparin Sales by Application in 2024
5.15.7 Cisen Pharmaceutical Heparin Sales by Geographic Area in 2024
5.15.8 Cisen Pharmaceutical Recent Developments
6 North America
6.1 North America Heparin Market Size YoY Growth 2020-2031
6.2 North America Heparin Market Facts & Figures by Country
6.2.1 North America Heparin Sales by Country (2020-2031)
6.2.2 North America Heparin Revenue by Country (2020-2031)
6.3 North America Heparin Sales by Type (2020-2025)
6.4 North America Heparin Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Heparin Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Heparin Market Facts & Figures by Region
7.2.1 Asia-Pacific Heparin Sales by Region (2020-2031)
7.2.2 Asia-Pacific Heparin Revenue by Region (2020-2031)
7.3 Asia-Pacific Heparin Sales by Type (2020-2025)
7.4 Asia-Pacific Heparin Sales by Application (2020-2025)
8 Europe
8.1 Europe Heparin Market Size YoY Growth 2020-2031
8.2 Europe Heparin Market Facts & Figures by Country
8.2.1 Europe Heparin Sales by Country (2020-2031)
8.2.2 Europe Heparin Revenue by Country (2020-2031)
8.3 Europe Heparin Sales by Type (2020-2025)
8.4 Europe Heparin Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Heparin Market Size YoY Growth 2020-2031
9.2 Latin America Heparin Market Facts & Figures by Country
9.2.1 Latin America Heparin Sales by Country (2020-2031)
9.2.2 Latin America Heparin Revenue by Country (2020-2031)
9.3 Latin America Heparin Sales by Type (2020-2025)
9.4 Latin America Heparin Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Heparin Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Heparin Market Facts & Figures by Country
10.2.1 Middle East and Africa Heparin Sales by Country (2020-2031)
10.2.2 Middle East and Africa Heparin Revenue by Country (2020-2031)
10.3 Middle East and Africa Heparin Sales by Type (2020-2025)
10.4 Middle East and Africa Heparin Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Heparin Supply Chain Analysis
11.2 Heparin Key Raw Materials and Upstream Suppliers
11.3 Heparin Clients Analysis
11.4 Heparin Sales Channel and Sales Model Analysis
11.4.1 Heparin Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Heparin Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Heparin Distributors
12 Heparin Market Dynamics
12.1 Heparin Industry Trends
12.2 Heparin Market Drivers
12.3 Heparin Market Challenges
12.4 Heparin Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Heparin Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Heparin Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Heparin Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Heparin Sales by Region (2020-2025) & (B Units)
Table 5. Global Heparin Sales Forecast by Region (2026-2031) & (B Units)
Table 6. Global Heparin Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Heparin Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Heparin Sales Volume by Type (2020-2025) & (B Units)
Table 9. Global Heparin Sales Volume by Type (2026-2031) & (B Units)
Table 10. Global Heparin Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Heparin Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Heparin Sales Volume by Application (2020-2025) & (B Units)
Table 13. Global Heparin Sales Volume by Application (2026-2031) & (B Units)
Table 14. Global Heparin Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Heparin Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Heparin Sales by Manufacturer (2020-2025) & (B Units)
Table 17. Global Heparin Sales Share by Manufacturer (2020-2025)
Table 18. Heparin Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Heparin Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Heparin Price (2020-2025) & (US$/B Units)
Table 21. Ranking of Global Top Heparin Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Heparin Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Heparin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin as of 2024)
Table 24. Heparin Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Heparin Market
Table 26. Manufacturers Heparin Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Shenzhen Hepalink Pharmaceutical Company Information
Table 29. Shenzhen Hepalink Pharmaceutical Description and Business Overview
Table 30. Shenzhen Hepalink Pharmaceutical Heparin Product
Table 31. Shenzhen Hepalink Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 32. Shenzhen Hepalink Pharmaceutical Sales Proportion of Heparin by Product in 2024
Table 33. Shenzhen Hepalink Pharmaceutical Sales Proportion of Heparin by Application in 2024
Table 34. Shenzhen Hepalink Pharmaceutical Sales Proportion of Heparin by Geographic Area in 2024
Table 35. Shenzhen Hepalink Pharmaceutical Recent Developments
Table 36. Yantai Dongcheng Pharmaceutical Company Information
Table 37. Yantai Dongcheng Pharmaceutical Description and Business Overview
Table 38. Yantai Dongcheng Pharmaceutical Heparin Product
Table 39. Yantai Dongcheng Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 40. Yantai Dongcheng Pharmaceutical Sales Proportion of Heparin by Product in 2024
Table 41. Yantai Dongcheng Pharmaceutical Sales Proportion of Heparin by Application in 2024
Table 42. Yantai Dongcheng Pharmaceutical Sales Proportion of Heparin by Geographic Area in 2024
Table 43. Yantai Dongcheng Pharmaceutical Recent Developments
Table 44. Pfizer Company Information
Table 45. Pfizer Description and Business Overview
Table 46. Pfizer Heparin Product
Table 47. Pfizer Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 48. Pfizer Sales Proportion of Heparin by Product in 2024
Table 49. Pfizer Sales Proportion of Heparin by Application in 2024
Table 50. Pfizer Sales Proportion of Heparin by Geographic Area in 2024
Table 51. Pfizer Recent Developments
Table 52. Bioibérica Company Information
Table 53. Bioibérica Description and Business Overview
Table 54. Bioibérica Heparin Product
Table 55. Bioibérica Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 56. Bioibérica Sales Proportion of Heparin by Product in 2024
Table 57. Bioibérica Sales Proportion of Heparin by Application in 2024
Table 58. Bioibérica Sales Proportion of Heparin by Geographic Area in 2024
Table 59. Bioibérica Recent Developments
Table 60. Changzhou Qianhong Biopharma Company Information
Table 61. Changzhou Qianhong Biopharma Description and Business Overview
Table 62. Changzhou Qianhong Biopharma Heparin Product
Table 63. Changzhou Qianhong Biopharma Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 64. Changzhou Qianhong Biopharma Sales Proportion of Heparin by Product in 2024
Table 65. Changzhou Qianhong Biopharma Sales Proportion of Heparin by Application in 2024
Table 66. Changzhou Qianhong Biopharma Sales Proportion of Heparin by Geographic Area in 2024
Table 67. Changzhou Qianhong Biopharma Recent Developments
Table 68. Nanjing King-friend Biochemical Pharmaceutical Company Information
Table 69. Nanjing King-friend Biochemical Pharmaceutical Description and Business Overview
Table 70. Nanjing King-friend Biochemical Pharmaceutical Heparin Product
Table 71. Nanjing King-friend Biochemical Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 72. Nanjing King-friend Biochemical Pharmaceutical Sales Proportion of Heparin by Product in 2024
Table 73. Nanjing King-friend Biochemical Pharmaceutical Sales Proportion of Heparin by Application in 2024
Table 74. Nanjing King-friend Biochemical Pharmaceutical Sales Proportion of Heparin by Geographic Area in 2024
Table 75. Nanjing King-friend Biochemical Pharmaceutical Recent Developments
Table 76. Hebei Changshan Biochemical Pharmaceutical Company Information
Table 77. Hebei Changshan Biochemical Pharmaceutical Description and Business Overview
Table 78. Hebei Changshan Biochemical Pharmaceutical Heparin Product
Table 79. Hebei Changshan Biochemical Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 80. Hebei Changshan Biochemical Pharmaceutical Sales Proportion of Heparin by Product in 2024
Table 81. Hebei Changshan Biochemical Pharmaceutical Sales Proportion of Heparin by Application in 2024
Table 82. Hebei Changshan Biochemical Pharmaceutical Sales Proportion of Heparin by Geographic Area in 2024
Table 83. Hebei Changshan Biochemical Pharmaceutical Recent Developments
Table 84. Qingdao Jiulong Biopharmaceutical Company Information
Table 85. Qingdao Jiulong Biopharmaceutical Description and Business Overview
Table 86. Qingdao Jiulong Biopharmaceutical Heparin Product
Table 87. Qingdao Jiulong Biopharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 88. Qingdao Jiulong Biopharmaceutical Sales Proportion of Heparin by Product in 2024
Table 89. Qingdao Jiulong Biopharmaceutical Sales Proportion of Heparin by Application in 2024
Table 90. Qingdao Jiulong Biopharmaceutical Sales Proportion of Heparin by Geographic Area in 2024
Table 91. Qingdao Jiulong Biopharmaceutical Recent Developments
Table 92. Opocrin Company Information
Table 93. Opocrin Description and Business Overview
Table 94. Opocrin Heparin Product
Table 95. Opocrin Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 96. Opocrin Sales Proportion of Heparin by Product in 2024
Table 97. Opocrin Sales Proportion of Heparin by Application in 2024
Table 98. Opocrin Sales Proportion of Heparin by Geographic Area in 2024
Table 99. Opocrin Recent Developments
Table 100. Dongying Tiandong Pharmaceutical Company Information
Table 101. Dongying Tiandong Pharmaceutical Description and Business Overview
Table 102. Dongying Tiandong Pharmaceutical Heparin Product
Table 103. Dongying Tiandong Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 104. Dongying Tiandong Pharmaceutical Sales Proportion of Heparin by Product in 2024
Table 105. Dongying Tiandong Pharmaceutical Sales Proportion of Heparin by Application in 2024
Table 106. Dongying Tiandong Pharmaceutical Sales Proportion of Heparin by Geographic Area in 2024
Table 107. Dongying Tiandong Pharmaceutical Recent Developments
Table 108. Aspen Oss Company Information
Table 109. Aspen Oss Description and Business Overview
Table 110. Aspen Oss Heparin Product
Table 111. Aspen Oss Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 112. Aspen Oss Sales Proportion of Heparin by Product in 2024
Table 113. Aspen Oss Sales Proportion of Heparin by Application in 2024
Table 114. Aspen Oss Sales Proportion of Heparin by Geographic Area in 2024
Table 115. Aspen Oss Recent Developments
Table 116. Yino Pharma Company Information
Table 117. Yino Pharma Description and Business Overview
Table 118. Yino Pharma Heparin Product
Table 119. Yino Pharma Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 120. Yino Pharma Sales Proportion of Heparin by Product in 2024
Table 121. Yino Pharma Sales Proportion of Heparin by Application in 2024
Table 122. Yino Pharma Sales Proportion of Heparin by Geographic Area in 2024
Table 123. Yino Pharma Recent Developments
Table 124. Nanjing Xinbai Pharmaceutical Company Information
Table 125. Nanjing Xinbai Pharmaceutical Description and Business Overview
Table 126. Nanjing Xinbai Pharmaceutical Heparin Product
Table 127. Nanjing Xinbai Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 128. Nanjing Xinbai Pharmaceutical Sales Proportion of Heparin by Product in 2024
Table 129. Nanjing Xinbai Pharmaceutical Sales Proportion of Heparin by Application in 2024
Table 130. Nanjing Xinbai Pharmaceutical Sales Proportion of Heparin by Geographic Area in 2024
Table 131. Nanjing Xinbai Pharmaceutical Recent Developments
Table 132. Hubei Enoray Biopharmaceutical Company Information
Table 133. Hubei Enoray Biopharmaceutical Description and Business Overview
Table 134. Hubei Enoray Biopharmaceutical Heparin Product
Table 135. Hubei Enoray Biopharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 136. Hubei Enoray Biopharmaceutical Sales Proportion of Heparin by Product in 2024
Table 137. Hubei Enoray Biopharmaceutical Sales Proportion of Heparin by Application in 2024
Table 138. Hubei Enoray Biopharmaceutical Sales Proportion of Heparin by Geographic Area in 2024
Table 139. Hubei Enoray Biopharmaceutical Recent Developments
Table 140. Cisen Pharmaceutical Company Information
Table 141. Cisen Pharmaceutical Description and Business Overview
Table 142. Cisen Pharmaceutical Heparin Product
Table 143. Cisen Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 144. Cisen Pharmaceutical Sales Proportion of Heparin by Product in 2024
Table 145. Cisen Pharmaceutical Sales Proportion of Heparin by Application in 2024
Table 146. Cisen Pharmaceutical Sales Proportion of Heparin by Geographic Area in 2024
Table 147. Cisen Pharmaceutical Recent Developments
Table 148. North America Heparin Sales by Country (2020-2025) & (B Units)
Table 149. North America Heparin Sales by Country (2026-2031) & (B Units)
Table 150. North America Heparin Revenue by Country (2020-2025) & (US$ Million)
Table 151. North America Heparin Revenue by Country (2026-2031) & (US$ Million)
Table 152. North America Heparin Sales by Type (2020-2025) & (B Units)
Table 153. North America Heparin Sales by Application (2020-2025) & (B Units)
Table 154. Asia-Pacific Heparin Sales by Region (2020-2025) & (B Units)
Table 155. Asia-Pacific Heparin Sales by Region (2026-2031) & (B Units)
Table 156. Asia-Pacific Heparin Revenue by Region (2020-2025) & (US$ Million)
Table 157. Asia-Pacific Heparin Revenue by Region (2026-2031) & (US$ Million)
Table 158. Asia-Pacific Heparin Sales by Type (2020-2025) & (B Units)
Table 159. Asia-Pacific Heparin Sales by Application (2020-2025) & (B Units)
Table 160. Europe Heparin Sales by Country (2020-2025) & (B Units)
Table 161. Europe Heparin Sales by Country (2026-2031) & (B Units)
Table 162. Europe Heparin Revenue by Country (2020-2025) & (US$ Million)
Table 163. Europe Heparin Revenue by Country (2026-2031) & (US$ Million)
Table 164. Europe Heparin Sales by Type (2020-2025) & (B Units)
Table 165. Europe Heparin Sales by Application (2020-2025) & (B Units)
Table 166. Latin America Heparin Sales by Country (2020-2025) & (B Units)
Table 167. Latin America Heparin Sales by Country (2026-2031) & (B Units)
Table 168. Latin America Heparin Revenue by Country (2020-2025) & (US$ Million)
Table 169. Latin America Heparin Revenue by Country (2026-2031) & (US$ Million)
Table 170. Latin America Heparin Sales by Type (2020-2025) & (B Units)
Table 171. Latin America Heparin Sales by Application (2020-2025) & (B Units)
Table 172. Middle East and Africa Heparin Sales by Country (2020-2025) & (B Units)
Table 173. Middle East and Africa Heparin Sales by Country (2026-2031) & (B Units)
Table 174. Middle East and Africa Heparin Revenue by Country (2020-2025) & (US$ Million)
Table 175. Middle East and Africa Heparin Revenue by Country (2026-2031) & (US$ Million)
Table 176. Middle East and Africa Heparin Sales by Type (2020-2025) & (B Units)
Table 177. Middle East and Africa Heparin Sales by Application (2020-2025) & (B Units)
Table 178. Heparin Key Raw Materials, Industry Status and Trend
Table 179. Heparin Key Raw Materials and Upstream Suppliers
Table 180. Heparin Clients Status and Trend
Table 181. Heparin Typical Clients
Table 182. Heparin Distributors
Table 183. Heparin Market Trends
Table 184. Heparin Market Drivers
Table 185. Heparin Market Challenges
Table 186. Heparin Market Restraints
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
Table 190. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Heparin Product Picture
Figure 2. Global Heparin Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Heparin Sales Market Share by Type in 2024 & 2031
Figure 4. Heparin Sodium Product Picture
Figure 5. Heparin Calcium Product Picture
Figure 6. Global Heparin Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Heparin Sales Market Share by Application in 2024 & 2031
Figure 8. UFH
Figure 9. LMWH
Figure 10. Heparin Report Years Considered
Figure 11. Global Heparin Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Heparin Market Size 2020-2031 (US$ Million)
Figure 13. Global Heparin Sales 2020-2031 (B Units)
Figure 14. Global Heparin Sales Market Share Forecast by Region (2020-2031)
Figure 15. Global Heparin Revenue Market Share by Region (2020-2031)
Figure 16. Global Heparin Sales Market Share Forecast by Type (2020-2031)
Figure 17. Global Heparin Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Heparin Average Selling Price (ASP) by Type (2020-2025) & (US$/B Units)
Figure 19. Global Heparin Sales Market Share Forecast by Application (2020-2031)
Figure 20. Global Heparin Revenue Market Share Forecast by Application (2020-2031)
Figure 21. Heparin Average Selling Price (ASP) by Application (2020-2025) & (US$/B Units)
Figure 22. Heparin Sodium of Heparin Revenue Market Share by Application, 2024 VS 2031
Figure 23. Heparin Calcium of Heparin Revenue Market Share by Application, 2024 VS 2031
Figure 24. Global Heparin Sales Share by Manufacturer in 2024
Figure 25. Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Heparin Sodium Market Sales Proportion by Manufacturer in 2024
Figure 27. Heparin Calcium Market Sales Proportion by Manufacturer in 2024
Figure 28. North America Heparin Revenue 2020-2031 (US$ Million)
Figure 29. North America Heparin Sales Market Share by Type (2020-2025)
Figure 30. North America Heparin Sales Market Share by Application (2020-2025)
Figure 31. Asia-Pacific Heparin Revenue 2020-2031 (US$ Million)
Figure 32. Asia-Pacific Heparin Sales Market Share by Region (2020-2031)
Figure 33. Asia-Pacific Heparin Revenue Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Heparin Sales Market Share by Type (2020-2025)
Figure 35. Asia-Pacific Heparin Sales Market Share by Application (2020-2025)
Figure 36. Europe Heparin Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Europe Heparin Sales Market Share by Country (2020-2031)
Figure 38. Europe Heparin Revenue Market Share by Country (2020-2031)
Figure 39. Europe Heparin Sales Market Share by Type (2020-2025)
Figure 40. Europe Heparin Sales Market Share by Application (2020-2025)
Figure 41. Latin America Heparin Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Latin America Heparin Sales Market Share by Country (2020-2031)
Figure 43. Latin America Heparin Revenue Market Share by Country (2020-2025)
Figure 44. Latin America Heparin Sales Market Share by Type (2020-2025)
Figure 45. Latin America Heparin Sales Market Share by Application (2020-2025)
Figure 46. Middle East and Africa Heparin Revenue Growth Rate 2020-2031 (US$ Million)
Figure 47. Middle East and Africa Heparin Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Heparin Revenue Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Heparin Sales Market Share by Type (2020-2025)
Figure 50. Middle East and Africa Heparin Sales Market Share by Application (2020-2025)
Figure 51. Heparin Supply Chain (Upstream and Downstream Market)
Figure 52. Global Production Market Share of Heparin Raw Materials by Region in 2024
Figure 53. Heparin Distribution Channels
Figure 54. Global Heparin Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 55. Global Heparin Percentage 2020-2031: Online Sales VS Offline Sales
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Table 1. Global Heparin Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Heparin Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Heparin Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Heparin Sales by Region (2020-2025) & (B Units)
Table 5. Global Heparin Sales Forecast by Region (2026-2031) & (B Units)
Table 6. Global Heparin Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Heparin Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Heparin Sales Volume by Type (2020-2025) & (B Units)
Table 9. Global Heparin Sales Volume by Type (2026-2031) & (B Units)
Table 10. Global Heparin Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Heparin Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Heparin Sales Volume by Application (2020-2025) & (B Units)
Table 13. Global Heparin Sales Volume by Application (2026-2031) & (B Units)
Table 14. Global Heparin Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Heparin Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Heparin Sales by Manufacturer (2020-2025) & (B Units)
Table 17. Global Heparin Sales Share by Manufacturer (2020-2025)
Table 18. Heparin Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Heparin Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Heparin Price (2020-2025) & (US$/B Units)
Table 21. Ranking of Global Top Heparin Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Heparin Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Heparin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin as of 2024)
Table 24. Heparin Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Heparin Market
Table 26. Manufacturers Heparin Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Shenzhen Hepalink Pharmaceutical Company Information
Table 29. Shenzhen Hepalink Pharmaceutical Description and Business Overview
Table 30. Shenzhen Hepalink Pharmaceutical Heparin Product
Table 31. Shenzhen Hepalink Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 32. Shenzhen Hepalink Pharmaceutical Sales Proportion of Heparin by Product in 2024
Table 33. Shenzhen Hepalink Pharmaceutical Sales Proportion of Heparin by Application in 2024
Table 34. Shenzhen Hepalink Pharmaceutical Sales Proportion of Heparin by Geographic Area in 2024
Table 35. Shenzhen Hepalink Pharmaceutical Recent Developments
Table 36. Yantai Dongcheng Pharmaceutical Company Information
Table 37. Yantai Dongcheng Pharmaceutical Description and Business Overview
Table 38. Yantai Dongcheng Pharmaceutical Heparin Product
Table 39. Yantai Dongcheng Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 40. Yantai Dongcheng Pharmaceutical Sales Proportion of Heparin by Product in 2024
Table 41. Yantai Dongcheng Pharmaceutical Sales Proportion of Heparin by Application in 2024
Table 42. Yantai Dongcheng Pharmaceutical Sales Proportion of Heparin by Geographic Area in 2024
Table 43. Yantai Dongcheng Pharmaceutical Recent Developments
Table 44. Pfizer Company Information
Table 45. Pfizer Description and Business Overview
Table 46. Pfizer Heparin Product
Table 47. Pfizer Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 48. Pfizer Sales Proportion of Heparin by Product in 2024
Table 49. Pfizer Sales Proportion of Heparin by Application in 2024
Table 50. Pfizer Sales Proportion of Heparin by Geographic Area in 2024
Table 51. Pfizer Recent Developments
Table 52. Bioibérica Company Information
Table 53. Bioibérica Description and Business Overview
Table 54. Bioibérica Heparin Product
Table 55. Bioibérica Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 56. Bioibérica Sales Proportion of Heparin by Product in 2024
Table 57. Bioibérica Sales Proportion of Heparin by Application in 2024
Table 58. Bioibérica Sales Proportion of Heparin by Geographic Area in 2024
Table 59. Bioibérica Recent Developments
Table 60. Changzhou Qianhong Biopharma Company Information
Table 61. Changzhou Qianhong Biopharma Description and Business Overview
Table 62. Changzhou Qianhong Biopharma Heparin Product
Table 63. Changzhou Qianhong Biopharma Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 64. Changzhou Qianhong Biopharma Sales Proportion of Heparin by Product in 2024
Table 65. Changzhou Qianhong Biopharma Sales Proportion of Heparin by Application in 2024
Table 66. Changzhou Qianhong Biopharma Sales Proportion of Heparin by Geographic Area in 2024
Table 67. Changzhou Qianhong Biopharma Recent Developments
Table 68. Nanjing King-friend Biochemical Pharmaceutical Company Information
Table 69. Nanjing King-friend Biochemical Pharmaceutical Description and Business Overview
Table 70. Nanjing King-friend Biochemical Pharmaceutical Heparin Product
Table 71. Nanjing King-friend Biochemical Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 72. Nanjing King-friend Biochemical Pharmaceutical Sales Proportion of Heparin by Product in 2024
Table 73. Nanjing King-friend Biochemical Pharmaceutical Sales Proportion of Heparin by Application in 2024
Table 74. Nanjing King-friend Biochemical Pharmaceutical Sales Proportion of Heparin by Geographic Area in 2024
Table 75. Nanjing King-friend Biochemical Pharmaceutical Recent Developments
Table 76. Hebei Changshan Biochemical Pharmaceutical Company Information
Table 77. Hebei Changshan Biochemical Pharmaceutical Description and Business Overview
Table 78. Hebei Changshan Biochemical Pharmaceutical Heparin Product
Table 79. Hebei Changshan Biochemical Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 80. Hebei Changshan Biochemical Pharmaceutical Sales Proportion of Heparin by Product in 2024
Table 81. Hebei Changshan Biochemical Pharmaceutical Sales Proportion of Heparin by Application in 2024
Table 82. Hebei Changshan Biochemical Pharmaceutical Sales Proportion of Heparin by Geographic Area in 2024
Table 83. Hebei Changshan Biochemical Pharmaceutical Recent Developments
Table 84. Qingdao Jiulong Biopharmaceutical Company Information
Table 85. Qingdao Jiulong Biopharmaceutical Description and Business Overview
Table 86. Qingdao Jiulong Biopharmaceutical Heparin Product
Table 87. Qingdao Jiulong Biopharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 88. Qingdao Jiulong Biopharmaceutical Sales Proportion of Heparin by Product in 2024
Table 89. Qingdao Jiulong Biopharmaceutical Sales Proportion of Heparin by Application in 2024
Table 90. Qingdao Jiulong Biopharmaceutical Sales Proportion of Heparin by Geographic Area in 2024
Table 91. Qingdao Jiulong Biopharmaceutical Recent Developments
Table 92. Opocrin Company Information
Table 93. Opocrin Description and Business Overview
Table 94. Opocrin Heparin Product
Table 95. Opocrin Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 96. Opocrin Sales Proportion of Heparin by Product in 2024
Table 97. Opocrin Sales Proportion of Heparin by Application in 2024
Table 98. Opocrin Sales Proportion of Heparin by Geographic Area in 2024
Table 99. Opocrin Recent Developments
Table 100. Dongying Tiandong Pharmaceutical Company Information
Table 101. Dongying Tiandong Pharmaceutical Description and Business Overview
Table 102. Dongying Tiandong Pharmaceutical Heparin Product
Table 103. Dongying Tiandong Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 104. Dongying Tiandong Pharmaceutical Sales Proportion of Heparin by Product in 2024
Table 105. Dongying Tiandong Pharmaceutical Sales Proportion of Heparin by Application in 2024
Table 106. Dongying Tiandong Pharmaceutical Sales Proportion of Heparin by Geographic Area in 2024
Table 107. Dongying Tiandong Pharmaceutical Recent Developments
Table 108. Aspen Oss Company Information
Table 109. Aspen Oss Description and Business Overview
Table 110. Aspen Oss Heparin Product
Table 111. Aspen Oss Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 112. Aspen Oss Sales Proportion of Heparin by Product in 2024
Table 113. Aspen Oss Sales Proportion of Heparin by Application in 2024
Table 114. Aspen Oss Sales Proportion of Heparin by Geographic Area in 2024
Table 115. Aspen Oss Recent Developments
Table 116. Yino Pharma Company Information
Table 117. Yino Pharma Description and Business Overview
Table 118. Yino Pharma Heparin Product
Table 119. Yino Pharma Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 120. Yino Pharma Sales Proportion of Heparin by Product in 2024
Table 121. Yino Pharma Sales Proportion of Heparin by Application in 2024
Table 122. Yino Pharma Sales Proportion of Heparin by Geographic Area in 2024
Table 123. Yino Pharma Recent Developments
Table 124. Nanjing Xinbai Pharmaceutical Company Information
Table 125. Nanjing Xinbai Pharmaceutical Description and Business Overview
Table 126. Nanjing Xinbai Pharmaceutical Heparin Product
Table 127. Nanjing Xinbai Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 128. Nanjing Xinbai Pharmaceutical Sales Proportion of Heparin by Product in 2024
Table 129. Nanjing Xinbai Pharmaceutical Sales Proportion of Heparin by Application in 2024
Table 130. Nanjing Xinbai Pharmaceutical Sales Proportion of Heparin by Geographic Area in 2024
Table 131. Nanjing Xinbai Pharmaceutical Recent Developments
Table 132. Hubei Enoray Biopharmaceutical Company Information
Table 133. Hubei Enoray Biopharmaceutical Description and Business Overview
Table 134. Hubei Enoray Biopharmaceutical Heparin Product
Table 135. Hubei Enoray Biopharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 136. Hubei Enoray Biopharmaceutical Sales Proportion of Heparin by Product in 2024
Table 137. Hubei Enoray Biopharmaceutical Sales Proportion of Heparin by Application in 2024
Table 138. Hubei Enoray Biopharmaceutical Sales Proportion of Heparin by Geographic Area in 2024
Table 139. Hubei Enoray Biopharmaceutical Recent Developments
Table 140. Cisen Pharmaceutical Company Information
Table 141. Cisen Pharmaceutical Description and Business Overview
Table 142. Cisen Pharmaceutical Heparin Product
Table 143. Cisen Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2020-2025)
Table 144. Cisen Pharmaceutical Sales Proportion of Heparin by Product in 2024
Table 145. Cisen Pharmaceutical Sales Proportion of Heparin by Application in 2024
Table 146. Cisen Pharmaceutical Sales Proportion of Heparin by Geographic Area in 2024
Table 147. Cisen Pharmaceutical Recent Developments
Table 148. North America Heparin Sales by Country (2020-2025) & (B Units)
Table 149. North America Heparin Sales by Country (2026-2031) & (B Units)
Table 150. North America Heparin Revenue by Country (2020-2025) & (US$ Million)
Table 151. North America Heparin Revenue by Country (2026-2031) & (US$ Million)
Table 152. North America Heparin Sales by Type (2020-2025) & (B Units)
Table 153. North America Heparin Sales by Application (2020-2025) & (B Units)
Table 154. Asia-Pacific Heparin Sales by Region (2020-2025) & (B Units)
Table 155. Asia-Pacific Heparin Sales by Region (2026-2031) & (B Units)
Table 156. Asia-Pacific Heparin Revenue by Region (2020-2025) & (US$ Million)
Table 157. Asia-Pacific Heparin Revenue by Region (2026-2031) & (US$ Million)
Table 158. Asia-Pacific Heparin Sales by Type (2020-2025) & (B Units)
Table 159. Asia-Pacific Heparin Sales by Application (2020-2025) & (B Units)
Table 160. Europe Heparin Sales by Country (2020-2025) & (B Units)
Table 161. Europe Heparin Sales by Country (2026-2031) & (B Units)
Table 162. Europe Heparin Revenue by Country (2020-2025) & (US$ Million)
Table 163. Europe Heparin Revenue by Country (2026-2031) & (US$ Million)
Table 164. Europe Heparin Sales by Type (2020-2025) & (B Units)
Table 165. Europe Heparin Sales by Application (2020-2025) & (B Units)
Table 166. Latin America Heparin Sales by Country (2020-2025) & (B Units)
Table 167. Latin America Heparin Sales by Country (2026-2031) & (B Units)
Table 168. Latin America Heparin Revenue by Country (2020-2025) & (US$ Million)
Table 169. Latin America Heparin Revenue by Country (2026-2031) & (US$ Million)
Table 170. Latin America Heparin Sales by Type (2020-2025) & (B Units)
Table 171. Latin America Heparin Sales by Application (2020-2025) & (B Units)
Table 172. Middle East and Africa Heparin Sales by Country (2020-2025) & (B Units)
Table 173. Middle East and Africa Heparin Sales by Country (2026-2031) & (B Units)
Table 174. Middle East and Africa Heparin Revenue by Country (2020-2025) & (US$ Million)
Table 175. Middle East and Africa Heparin Revenue by Country (2026-2031) & (US$ Million)
Table 176. Middle East and Africa Heparin Sales by Type (2020-2025) & (B Units)
Table 177. Middle East and Africa Heparin Sales by Application (2020-2025) & (B Units)
Table 178. Heparin Key Raw Materials, Industry Status and Trend
Table 179. Heparin Key Raw Materials and Upstream Suppliers
Table 180. Heparin Clients Status and Trend
Table 181. Heparin Typical Clients
Table 182. Heparin Distributors
Table 183. Heparin Market Trends
Table 184. Heparin Market Drivers
Table 185. Heparin Market Challenges
Table 186. Heparin Market Restraints
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
Table 190. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Heparin Product Picture
Figure 2. Global Heparin Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Heparin Sales Market Share by Type in 2024 & 2031
Figure 4. Heparin Sodium Product Picture
Figure 5. Heparin Calcium Product Picture
Figure 6. Global Heparin Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Heparin Sales Market Share by Application in 2024 & 2031
Figure 8. UFH
Figure 9. LMWH
Figure 10. Heparin Report Years Considered
Figure 11. Global Heparin Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Heparin Market Size 2020-2031 (US$ Million)
Figure 13. Global Heparin Sales 2020-2031 (B Units)
Figure 14. Global Heparin Sales Market Share Forecast by Region (2020-2031)
Figure 15. Global Heparin Revenue Market Share by Region (2020-2031)
Figure 16. Global Heparin Sales Market Share Forecast by Type (2020-2031)
Figure 17. Global Heparin Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Heparin Average Selling Price (ASP) by Type (2020-2025) & (US$/B Units)
Figure 19. Global Heparin Sales Market Share Forecast by Application (2020-2031)
Figure 20. Global Heparin Revenue Market Share Forecast by Application (2020-2031)
Figure 21. Heparin Average Selling Price (ASP) by Application (2020-2025) & (US$/B Units)
Figure 22. Heparin Sodium of Heparin Revenue Market Share by Application, 2024 VS 2031
Figure 23. Heparin Calcium of Heparin Revenue Market Share by Application, 2024 VS 2031
Figure 24. Global Heparin Sales Share by Manufacturer in 2024
Figure 25. Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Heparin Sodium Market Sales Proportion by Manufacturer in 2024
Figure 27. Heparin Calcium Market Sales Proportion by Manufacturer in 2024
Figure 28. North America Heparin Revenue 2020-2031 (US$ Million)
Figure 29. North America Heparin Sales Market Share by Type (2020-2025)
Figure 30. North America Heparin Sales Market Share by Application (2020-2025)
Figure 31. Asia-Pacific Heparin Revenue 2020-2031 (US$ Million)
Figure 32. Asia-Pacific Heparin Sales Market Share by Region (2020-2031)
Figure 33. Asia-Pacific Heparin Revenue Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Heparin Sales Market Share by Type (2020-2025)
Figure 35. Asia-Pacific Heparin Sales Market Share by Application (2020-2025)
Figure 36. Europe Heparin Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Europe Heparin Sales Market Share by Country (2020-2031)
Figure 38. Europe Heparin Revenue Market Share by Country (2020-2031)
Figure 39. Europe Heparin Sales Market Share by Type (2020-2025)
Figure 40. Europe Heparin Sales Market Share by Application (2020-2025)
Figure 41. Latin America Heparin Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Latin America Heparin Sales Market Share by Country (2020-2031)
Figure 43. Latin America Heparin Revenue Market Share by Country (2020-2025)
Figure 44. Latin America Heparin Sales Market Share by Type (2020-2025)
Figure 45. Latin America Heparin Sales Market Share by Application (2020-2025)
Figure 46. Middle East and Africa Heparin Revenue Growth Rate 2020-2031 (US$ Million)
Figure 47. Middle East and Africa Heparin Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Heparin Revenue Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Heparin Sales Market Share by Type (2020-2025)
Figure 50. Middle East and Africa Heparin Sales Market Share by Application (2020-2025)
Figure 51. Heparin Supply Chain (Upstream and Downstream Market)
Figure 52. Global Production Market Share of Heparin Raw Materials by Region in 2024
Figure 53. Heparin Distribution Channels
Figure 54. Global Heparin Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 55. Global Heparin Percentage 2020-2031: Online Sales VS Offline Sales
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232